Abbott Laboratories closed 11.85% below its 52-week high of $141.23, which the company achieved on March 4th.

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Abbott Laboratories closed 10.05% below its 52-week high of $141.23, which the company reached on March 4th.

We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a ...

To get a sense of who is truly in control of Abbott Laboratories (NYSE:ABT), it is important to understand the ownership structure of the business. With 79% stake, institutions possess the maximum ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare are included in this Analyst Blog.

A leader in Abbott's Heart Failure division announced that the company named Dr. Finn Gustafsson as the unit's chief medical ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Abbott (ABT) announced late-breaking data from its Triluminate Pivotal trial that show the TriClip transcatheter edge-to-edge repair system to ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and ...